Work

A Phase I/II Trial of Bortezomib, Tacrolimus and Methotrexate for Prophylaxis of Acute Graft Versus Host Disease after HLA Mismatched Reduced Intensity Transplantation.

Year: 2008

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v112.11.1158.1158

Authors: John Koreth, Kristen Stevenson, Haesook T Kim, Vincent T Ho, Corey S Cutler, Philippe Armand, Robert J Soiffer, Joseph H Antin, Edwin P Alyea

Institution: Dana-Farber Cancer Institute

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2994215274

FWCI: 0.431

Cites:

Cited by: 2

Related to: 10